— Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter — — Delivered $1.0 Million of Operating Income in Q3 2025 — SAN DIEGO, Nov. 13, 2025 /PRNewswire/ — Women’s health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
